We found that previous related reports were named “PD-1 inhibitor or ICI-induced T1DM” (Clotman et al., 2018; Baden et al., 2018; de Filette et al., 2019) or “fulminant T1DM” (Okamoto et al., 2016; Kong et al., 2023; Rui and Zhu, 2023; Zhang et al., 2024) or “PD-1 inhibitor or ICI-induced IDDM” (Stamatouli et al., 2018; Kotwal et al., 2019). This evidence concerns the gene PDCD1 and type 1 diabetes mellitus.